In GSCs, Nrf2 expression is upregulated compared to non-stem glioma cells, leading to increased glutathione peroxidase 1 (GPx1) transcription and decreased ROS levels, which contributes to their radio-resistance [109]. The gene discussed is GPX1; the disease is central nervous system cancer.